CBI 2025 China Bio Conf: 256 Experts on CGT/Peptide/XDC/Nucleic Acid/Small Molecule

2025 China Bio Conference at Suzhou Int’l Expo Center, Aug 1-2: 80+ forums on CGT, peptide drugs, XDC tech, nucleic acid & small molecule drugs, covering clinical translation & global strategies.

1. Milestones in Global Biomedical Innovation

The CBI 2025 Biomedical Innovation Expo will be held on August 1-2, 2025, at the Suzhou International Expo Center E Hall. With the theme of “Breaking Boundaries, Coexisting,” the summit will bring together 256 of the world’s top scientists and industry leaders, including 23 listed company technology leaders, 37 biotech founders, and executives from multinational corporations such as Merck and Eli Lilly.

The conference will feature seven technical sub-forums covering:

• Cell and Gene Therapy (CGT): CAR-T therapy for solid tumors, AAV vector optimization, and stem cell clinical translation
• Peptide Drugs: Post-GLP-1 Era Weight Loss Therapies, Oral Delivery Technologies, Pediatric Endocrine Drug
• XDC Technology: ADC 3.0 Development, Nuclear Medicine Targeted Delivery, PDC Bone-Targeted Therapies
• Nucleic Acid Drugs: mRNA Vaccine Commercialization, LNP Delivery Systems, Small Nucleic Acid CMC Challenges

2. Technological Frontiers: Breakthrough Agenda in Five Key Areas

2.1.Cell and Gene Therapy (CGT) Forum

CAR-T Technology Iteration

• Yang Lin (Bosonji Pharmaceutical): Optimization Strategies for Solid Tumor CAR-T Based on the CD19 Target, Overcoming Limitations of the Immune Microenvironment
• Xie Xuanhui (Tunlu Bio): Open Innovation Model to Overcome the “Death Valley” of In Vivo CAR-T, Shortening the Clinical Translation Pathway

AAV Gene Therapy

Zhang Guiyi (Huayi Science): Clinical Progress of Liver-Targeted Gene Therapy Technology, Dual-Plasmid Production Process Enhancing Vector Efficiency by 300%

2.2 Peptide Drug Development

Innovation in the Post-GLP-1 Era

• Sun Kaoxiang (Green Leaf Pharmaceutical): Oral weight loss therapy CG-0416/GLP-1RA combination regimen reduces muscle loss side effects
• Fang Yongliang (Daoer Bio): Clinical translation pathways for multi-target agonists, breaking through the efficacy bottleneck of single-target therapies

Technological platform innovation

Zhang Genwei (Beijing Jingtai): AI-driven high-throughput peptide screening platform, reducing development cycles to one-third of traditional methods (Associated with the University of Sydney’s PROTEUS

2.3. XDC Technology Ecosystem

ADC 3.0 Era

• Cai Jiaqiang (Yilian Bio): New target discovery strategies and toxicity control schemes to enhance the therapeutic window
• Yan Bin (Medix): Iterative development pathways for ADCs to overcome linker stability bottlenecks

Breakthroughs in Radiopharmaceuticals and PDCs

• Wu Yiquin (NuoRuiTe): Clinical progress in tumor-targeted radiopharmaceuticals and precise dose control technology (Targeted Coupling Technology Utilizing Bioconjugate Chemical Modifications)
• Lai Bo Rui Chen Team: Global First Stem Cell-Bone Dual-Targeted PDC Drug Design, Addressing Pain Points in Osteoporosis Treatment

3. Globalization Highlights: Cross-Border Collaboration and Regulatory Science

FDA and International Compliance Session

• Wang Yanning (Former FDA Review Director): New Trends in AI-Assisted Review and 21 CFR Part 11 Compliance Practices
• Bi Luchun (Leiboke): Regulatory Requirements for ADC Bioanalysis, Differentiated Strategies for Dual Reporting in China and the US

Cross-border BD and Licensing Transactions

• Merck/Eli Lilly/BeiGene Executive Roundtable: Analyzing Licensing Trends for Hot Targets in Oncology, CNS, and Immunology
• Shao Ke (Kexing Pharmaceutical): BD Risk Management Model Under Geopolitical Conditions

4. Conference Value: Technology Transfer and Resource Networking

Three Core Value Matrices
Industry Matching Platform
16 Roundtable Discussions Covering Process Development, Overseas Expansion Strategies, and Investment and Financing Roadshows
Access to Over 100,000 Professional Community Resources in the Pharmaceutical Industry
Frontier Technology Transfer

• First Disclosure of Over 30 Clinical Cases: Including Lingtai Bio’s Oral KRAS G12D PROTAC Drug and Weizhen Bio’s mRNA Vaccine Industrialization Data

Global Ecosystem Co-Construction

• Startup Pitching: On-site evaluations by Sequoia Capital/OrbiMed/Lilly Asia Ventures
• GMP Facility Tour: On-site visit to the 5,000L production base at Suzhou BioBay Industrial Park

5. Conference Basic Information

• Date: August 1-2, 2025
• Location: Suzhou International Expo Center Hall E (Suzhou International Expo Center), Suzhou, Jiangsu Province, China
• Scale: Over 8,000 professionals from 35 countries

Click here（2025 China Bio Conference at Suzhou Int’l Expo Center）for more details about the conference.

6. Recommended places for international visitors to eat, drink, and have fun near the exhibition held at Suzhou International Expo Center Hall E

Suzhou offers international visitors a relatively friendly public transportation environment. Whether by subway or bus, international visitors can reach their destinations relatively conveniently, making it a good choice for travel near the exhibition.

6.1 Recommended information is as follows:

6.1.1 Moonlight Pier

• Features:
  • Located on the northeast shore of Jinji Lake, it is ranked first among “Suzhou’s Top Ten Most Beautiful Night Views.” The architecture here primarily features authentic European-style designs, exuding an exotic ambiance. It offers a variety of dining options, including Japanese cuisine, Indian cuisine, Turkish-style restaurants, as well as music bars, cafes, tea houses, and vegetarian restaurants, catering to diverse taste preferences. Additionally, state-of-the-art floodlighting technology enhances its nighttime scenery, making it an ideal spot for leisure and entertainment.
• Transportation options:
  • Subway: From the Suzhou International Expo Center, walk to the Cultural Expo Center Station on Line 1, take Line 1 (towards Zhongnan Street), get off at Dongfang Gate Station after one stop, transfer to Line 3 (towards Weiting) at the station, get off at Yan Yu Bridge Station, exit from Exit 3, and walk approximately 600 meters to reach Moonlight Pier.
  • Bus: Take Bus No. 2, 47, 108, or 121 from the International Expo Center Station, get off at Qinyuan Residential Area Station, and walk approximately 500 meters to arrive.
• Notes:
  • Moonlight Pier is often crowded with tourists, especially in the evening. Please keep your belongings secure when traveling. Some restaurants may require reservations, especially during holidays or peak dining hours. It is recommended to check and book in advance. Please respect the dining etiquette and cultural customs of different restaurants.

6.1.2 Suzhou Cultural Arts Center

• Features:
  • Adjacent to the Expo Center, it integrates multiple functions such as performances, exhibitions, and film and television. It frequently hosts various art exhibitions, concerts, theater performances, and other cultural activities, allowing international visitors to experience a diverse artistic atmosphere. There is also a dining area offering a variety of cuisines.
• Transportation:
  • Subway: Take the subway from the Suzhou International Expo Center to the Cultural Expo Center Station on Line 1, exit at Exit 3, and walk approximately 100–200 meters to reach the Suzhou Cultural Arts Center.
  • Bus: Take bus routes such as Route 2 or Route 47 from the International Expo Center Station, and the center is a short walk from the bus stop.
• Notes:
  • Check the cultural arts center’s event schedule in advance to plan your itinerary accordingly; when attending performances or exhibitions, adhere to venue regulations such as no photography and maintaining quiet.

6.1.3 Yuanrong Times Square

• Features:
  • It is a large commercial complex with numerous fashion brands, restaurants, cinemas, etc. There is a sky-roofed district where, after dark, the sky-roof displays a dazzling light and shadow show, making it a highly scenic spot and a hub for shopping, dining, and leisure activities.
• Transportation:
  • Subway: Walk from the Suzhou International Expo Center to the Times Square Station on Line 1 of the subway. Exit at Exit 1 to reach Yuanrong Times Square.
  • Bus: Take Bus Route 2, 47, or 127 from the East Station of the International Expo Center and get off at Times Square Station.
• Notes:
  • Weekends and holidays are busy, so shopping and dining may require waiting in line; the square is large, so be sure to orient yourself to avoid getting lost.

Hello, if you have any other questions, feel free to leave a message, and I will continue to collect and organize information. Thank you.

7. Join the discussion and share your thoughts:

7.1 GLP-1 Peptide Drugs: A Research and Development Bubble Fueled by the “Weight Loss Boom”?

• In the post-GLP-1 era, companies are flocking to develop “oral delivery + multi-target agonists,” but side effects such as muscle loss remain unresolved, and the over-concentration of indications on weight loss may trigger intense competition in a saturated market.
• Clinicians warn that “overcommercialization may overlook essential needs like diabetes,” yet capital continues to pursue the “weight loss market exceeding 100 billion.”
• Do you believe that “peptide drug development has deviated from its medical essence”? How should we balance commercial trends with unmet clinical needs?

What are your thoughts on this situation? Please share your insights and join the discussion.